MeSH term
Frequency | Condition_Probility | Animals | 21 | 0.0 |
Humans | 38 | 0.0 |
Amino Acid Sequence | 12 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Cell Line | 6 | 0.0 |
DNA Primers | 2 | 0.0 |
Homeodomain Proteins/*genetics/metabolism | 2 | 2.0 |
In Situ Hybridization | 6 | 0.0 |
Mice | 14 | 0.0 |
Molecular Sequence Data | 21 | 0.0 |
Rats | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 32 | 0.0 |
Cattle | 4 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
Comparative Study | 3 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
Exons | 3 | 0.0 |
Gene Library | 3 | 0.0 |
Introns | 4 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Photoreceptors, Vertebrate/metabolism | 3 | 23.0 |
Radiation Hybrid Mapping | 2 | 2.0 |
Research Support, U.S. Gov't, P.H.S. | 23 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Base Sequence | 13 | 0.0 |
*Promoter Regions (Genetics) | 5 | 0.0 |
Rods (Retina)/*enzymology | 2 | 25.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Transfection | 7 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Xenopus | 2 | 0.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
*Eye Proteins | 3 | 1.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Eye Proteins/genetics | 2 | 4.0 |
Genotype | 3 | 0.0 |
Mutation | 4 | 0.0 |
Adult | 6 | 0.0 |
DNA Mutational Analysis | 5 | 0.0 |
Electroretinography | 3 | 1.0 |
Eye Proteins/*genetics | 4 | 2.0 |
Female | 10 | 0.0 |
Male | 7 | 0.0 |
*Membrane Glycoproteins | 3 | 0.0 |
Middle Aged | 4 | 0.0 |
Pedigree | 8 | 0.0 |
Phenotype | 7 | 0.0 |
*Point Mutation | 3 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Visual Acuity | 4 | 2.0 |
Binding Sites | 5 | 0.0 |
Conserved Sequence | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Luciferases/metabolism | 2 | 0.0 |
Opsin/genetics | 2 | 40.0 |
Phylogeny | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 8 | 0.0 |
Transgenes | 2 | 0.0 |
Disease Models, Animal | 3 | 0.0 |
Mice, Transgenic | 5 | 0.0 |
Protein Binding | 2 | 0.0 |
Trans-Activation (Genetics) | 4 | 0.0 |
Two-Hybrid System Techniques | 3 | 0.0 |
Homeodomain Proteins/*genetics/*metabolism | 3 | 10.0 |
Retina/embryology | 2 | 25.0 |
Species Specificity | 3 | 0.0 |
Time Factors | 2 | 0.0 |
Trans-Activators/*genetics/*metabolism | 3 | 8.0 |
Aged | 2 | 0.0 |
Child | 3 | 0.0 |
Child, Preschool | 2 | 0.0 |
Genes, Dominant | 5 | 0.0 |
Homeodomain Proteins/*genetics | 6 | 1.0 |
*Sequence Deletion | 2 | 0.0 |
Trans-Activators/*genetics | 6 | 1.0 |
Homeodomain Proteins/genetics | 2 | 0.0 |
Intermediate Filament Proteins/genetics | 2 | 12.0 |
*Mutation | 3 | 0.0 |
Nerve Tissue Proteins/genetics | 3 | 1.0 |
Rhodopsin/genetics | 4 | 21.0 |
Trans-Activators/genetics | 3 | 1.0 |
Variation (Genetics) | 2 | 0.0 |
Photoreceptors, Vertebrate/*metabolism | 3 | 18.0 |
Cells, Cultured | 2 | 0.0 |
DNA/metabolism | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Cell Nucleus/*metabolism | 2 | 0.0 |
Gene Expression | 4 | 0.0 |
Point Mutation | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Blindness/*genetics | 2 | 15.0 |
Mice, Knockout | 2 | 0.0 |
*Transcription, Genetic | 3 | 0.0 |
Evolution, Molecular | 2 | 0.0 |
Gene Expression Regulation, Developmental | 3 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Chromosome Mapping | 6 | 0.0 |
Hela Cells | 2 | 0.0 |
Retinal Degeneration/*genetics | 3 | 7.0 |
Amino Acid Substitution | 2 | 0.0 |
Retina/metabolism | 2 | 3.0 |
Homeodomain Proteins/metabolism | 2 | 2.0 |
Chromosomes, Human, Pair 19 | 2 | 1.0 |
Codon | 2 | 0.0 |
Promoter Regions (Genetics)/physiology | 2 | 1.0 |
Infant | 2 | 0.0 |
Blindness/congenital/*genetics | 2 | 28.0 |
